DUXAP9 and osteosarcoma: The expression of LINC01296 was found to be heightened in osteosarcoma (OS) cells and tissues, and there existed a positive correlation between the knockdown or overexpression of cyclin D1 and the expression of LINC01296, indicating LINC01296 to exert a carcinogenic effect on OS through cyclin D1 [32].